Healthcare Digital Marketing Strategy 2027: Connecting Trust, Access, and Growth
Healthcare digital marketing strategy should connect clinical credibility with a next step the institution can fulfill. For healthcare leaders, the investment decision spans brand, patient access, service capacity, professional relationships, and responsible measurement.
An executive perspective for hospitals, health systems, and large provider groups, with distinct considerations for pharmaceutical and medical technology organizations.
By Gigawatt Group · Research reviewed November 5, 2026 · For marketing, communications, access, operations, and commercial leaders
The executive perspective
Our central judgment: healthcare marketing performs a more useful role when the public promise, access experience, and evidence of response are planned together. Creative quality and channel expertise matter. Their value depends partly on the institution’s ability to explain an appropriate offer and follow through when people respond.
For 2027, leadership should resolve three questions before expanding investment: which audience action matters, whether the organization can support it, and what evidence will guide the next decision. Patient acquisition, referral development, reputation, workforce recruitment, and product commercialization need their own answers.
1. Healthcare digital marketing strategy begins with an access decision
Growth becomes useful when the institution can connect a relevant audience with an appropriate next step.
A healthcare digital marketing strategy connects institutional priorities with audiences, credible information, usable access, and evidence of response. For a health system or large medical group, it also connects marketing with the people who control scheduling, service capacity, clinical review, referral processes, and financial interpretation. The operating question is whether the organization can deliver the experience its campaign invites people to expect.
This perspective is written primarily for executives responsible for hospitals, health systems, and substantial multi-location provider organizations. It also addresses the different requirements of pharmaceutical and medical technology teams. These buyers may share a need for clear positioning, strong creative, and accountable execution. Their audiences, decision journeys, evidence requirements, and commercial outcomes need separate treatment.
A provider organization may want to introduce a new location, support an underused service, explain an affiliation, or build confidence in an established clinical program. Those goals imply different campaigns. A new clinic needs accurate local information and a functioning scheduling route. A specialist program may depend heavily on referring clinicians. An institutional reputation assignment may require sustained evidence that cannot be assessed through immediate appointment counts.
Choose the market and the reason to be considered
Market selection should bring together community needs, service capabilities, geography, patient preferences, referral patterns, and available capacity. A system should understand which alternatives people already consider and what evidence supports its own position. Clinical differentiation might involve a documented capability, an experienced multidisciplinary team, or a coordinated access model. The chosen promise needs support that prospective patients and referring professionals can inspect.
A campaign spanning Washington, Chicago, Ohio, New York City, or Atlanta still needs a local account of travel, language, referral networks, and service availability. City names alone do not establish relevance. Use the organization’s own research, appropriate public data, and conversations with local operators to decide where a particular proposition can be useful.
Institutional reputation also deserves a distinct investment thesis. Research leadership, community partnerships, workforce expertise, and dependable communication can support different forms of confidence. Define the audience whose understanding should change and the evidence available to evaluate that change. A reputation assignment needs an explicit time horizon and a credible research plan alongside its creative ambition.
Our judgment is that healthcare growth planning should identify the desired action before selecting the channel. That action might be a relevant scheduling request, a completed appointment, a clinician’s appropriate referral, an employer conversation, or a procurement meeting. Each requires a different destination and a different owner. The campaign should make the next step understandable without making the patient or professional responsible for coordinating the institution.
| Purpose | Audience action | Evidence to inspect |
|---|---|---|
| Patient access | Use an appropriate scheduling or inquiry route | Successful contact, scheduling, completed appointments |
| Referral development | Submit a relevant referral or professional inquiry | Accepted information, acknowledgment, documented progression |
| Institutional reputation | Understand and engage with credible expertise | Relevant reach, audience research, qualified stakeholder response |
| Clinician recruitment | Explore a suitable role and apply | Qualified candidates, interviews, hiring progression |
| Product commercialization | Advance an appropriate evaluation | Relevant stakeholders, documented opportunity, adoption requirements |
Gigawatt Group proposed framework. Clinical decisions remain with the appropriate professionals; commercial and communications measures retain separate definitions.
Consider a hypothetical health system opening an outpatient location while its central scheduling team still uses older routing instructions. Marketing can generate interest quickly. Callers may then be transferred between departments, told that a provider is unavailable, or directed to a distant location. The resulting frustration belongs in the growth discussion because the advertised promise and the operating experience are part of the same public relationship.
Leadership needs a shared brief across marketing, access operations, clinical leadership, technology, and finance. That brief should name the population the service is intended to reach, the access route, known limitations, the evidence required, and the decisions the team can make during delivery. Privacy and security owners should participate wherever the proposed work changes data collection or disclosure.
The available budget should cover the work required to make the campaign useful. Original content, clinical review, destination improvements, translation, media, operational coordination, and reporting all compete for resources. Treating the media allocation as the whole investment can leave the experience unfinished. A proposal should expose dependencies on internal teams so leadership can judge the complete commitment.
For 2027, we would prioritize the constraints that prevent a sound institutional proposition from becoming usable access. Sometimes that means better creative or broader distribution. Sometimes it means accurate provider information, clearer instructions, or stronger response handling. The institution’s objective determines the work; the channel plan follows that decision.
2. Service-line marketing has to reflect actual capacity
The ability to attract attention and the ability to offer timely access can move in different directions.
Healthcare service line marketing often begins with a growth priority: support a new specialist, expand awareness of an outpatient program, or strengthen the position of a regional center. The campaign brief should also establish where capacity exists, which appointment types are available, how referrals are handled, and who can update that information. A broad service label can conceal substantial variation across providers and locations.
AMN Healthcare’s 2025 study reported average waits ranging from 12 days in orthopedic surgery to 41.8 days in obstetrics/gynecology for its specified new-patient scenarios. It does not describe every practice or a patient’s clinically appropriate waiting time. [1]
| Specialty | Average wait, days |
|---|---|
| Obstetrics/gynecology | 41.8 |
| Gastroenterology | 40.0 |
| Dermatology | 36.5 |
| Cardiology | 32.7 |
| Family medicine | 23.5 |
| Orthopedic surgery | 12.0 |
AMN Healthcare, 2025. Calls to 1,391 offices in 15 metropolitan areas, January 15–February 24, using specified non-emergent scenarios. A sampled access snapshot, not a representative estimate for every U.S. practice or clinical advice about waiting. [1]
The executive implication is practical. A campaign promoting a service with limited near-term access may need a different offer, geography, or launch date from one supporting an available team. Marketing should receive an accurate statement of capacity from the responsible operators. It should also understand which information can be communicated publicly and which decisions require clinical or scheduling judgment.
A hypothetical regional group might have available appointments at one location while a nearby site has a substantial backlog. A single regional campaign could distribute inquiries unevenly and intensify the backlog. Location-specific destinations, clear travel information, and an approved routing process can help people understand their options. Any redirection should remain consistent with the organization’s care model and the individual’s stated needs.
Capacity is also more specific than an empty calendar slot. A visit may require a certain clinician, equipment, referral information, or preparation. Marketing does not determine clinical eligibility. It needs access to approved descriptions and a reliable route to the team that can establish the next step. A scheduling request should never be reported as a completed clinical determination.
We recommend a recurring capacity conversation during consequential campaigns. The access owner reports material changes, the operator explains delivery and response, and the institution decides whether to continue, redirect, revise, or pause promotion. The cadence should follow the campaign’s speed and the service’s volatility. A quarterly strategy meeting may be too slow for a launch whose availability changes weekly.
Hospital service line marketing also benefits from explicit stopping conditions. These might include a broken scheduling route, persistent inability to contact interested people, or a change that makes the advertised availability inaccurate. The agency should know who can authorize a pause and who approves the replacement message. A useful escalation process protects both campaign performance and the institution’s credibility.
Capacity-informed investment can support responsible growth without assuming that every additional inquiry is valuable. Leadership should fund the combination of communication, access, and response that the service requires. The strongest proposal explains how the team will recognize when demand generation has become less useful than fixing the next operational constraint.
3. Patient acquisition depends on the whole access journey
Search, forms, calls, scheduling, and arrival need a connected account of what people are trying to do.
Healthcare patient acquisition can involve several systems and several moments of uncertainty. A person may discover a service through search, compare provider information, call with a practical question, receive a scheduling link, and complete an appointment weeks later. The institution should understand that sequence well enough to identify where it helps people proceed and where it creates avoidable work.
The appropriate destination depends on the request. A returning patient may need an existing portal. A person seeking a first appointment may need a public scheduling route. A caregiver may need instructions about authorized access. A referring office may need a professional workflow. Directing everyone to a generic contact form shifts the routing problem onto the person seeking help.
ASTP/ONC reports that the share of adults offered online access to their medical records rose from 59% in 2020 to 77% in 2024. The share both offered access and using it rose from 38% to 65%. These national self-reports describe portal access and use, not acquisition conversion or satisfaction with a particular health system. [2]
| Year | Offered online access | Offered and accessed |
|---|---|---|
| 2020 | 59% | 38% |
| 2022 | 73% | 57% |
| 2024 | 77% | 65% |
ASTP/ONC, HINTS data for 2020, 2022, and 2024. Both series are shares of all adults; the use series is not a percentage of those offered access. Self-reported, repeated cross-sectional observations, not a causal study. [2]
Growing digital participation makes clarity across public and authenticated experiences more important. A campaign can explain where an existing patient should go without assuming that everyone has an account or can use it easily. Telephone support, accessible forms, clear error messages, and a sensible alternative when a digital task fails should be considered part of the experience being promoted.
Review the journey from a person’s actual task. Can they tell which location provides the service? Is the difference between requesting and confirming an appointment clear? Do they understand which information is needed now and what will happen next? Are the instructions usable on a phone, with assistive technology, and in the languages the organization supports? These questions connect brand experience with practical access.
Cost and coverage information need careful ownership. Marketing can make approved explanations easier to find and identify the team responsible for specific questions. It should avoid turning general network participation or a broad price statement into a promise about an individual’s eligibility or final out-of-pocket cost. Clear routing is more useful than an assurance the campaign cannot substantiate.
AHRQ’s health literacy toolkit recommends simplifying communication, confirming understanding, and making healthcare easier to use. Applied to marketing, that supports plain-language instructions and evaluation with the intended audience. A readability score can help identify difficult text; task-based review establishes whether people understand the action and the information they need. [3]
Measurement should preserve the distinctions among inquiry, successful contact, scheduled appointment, and completed visit. Their timing and responsible systems differ. A missed step may reflect availability, administrative requirements, a change in preference, or a decision made with a clinician. The report should explain what is observable without treating every unfinished journey as a marketing failure.
The next investment should address the most consequential friction the organization can verify. That could be a clearer service page, accurate routing, a repaired mobile form, or better coordination with access teams. A well-defined improvement creates a more useful basis for patient acquisition than simply purchasing more traffic for the same incomplete journey.
4. Location accuracy is part of the healthcare brand
The public promise becomes credible when provider, location, and access information agree with the experience a person encounters.
A healthcare brand is experienced through practical details. A person searches for a clinician, checks a location, considers travel, and tries to arrange care. If the directory points to an old address or the scheduling route leads to the wrong team, the institution has created a confidence problem before a clinical encounter begins. Brand investment should include ownership of those details.
Large systems often hold several versions of the same information across provider profiles, service pages, location listings, campaign destinations, referral materials, and scheduling systems. A change in employment, affiliation, availability, or clinical focus can affect each version. Leadership should identify which team maintains the authoritative information and how updates reach the people and systems that publish it.
Give every location a usable account of access
A useful location page explains what is available there, whom to contact, and what the next step involves. It should distinguish a request for an appointment from a confirmed booking. Where services or scheduling arrangements differ, those differences should be visible. A common design can make the institution recognizable while giving each location enough specificity to help someone proceed.
Coverage and cost language need equally careful ownership. A general statement that a practice works with an insurer may leave questions about the individual clinician, service, plan, or location. The page should direct people to the appropriate verification process and explain who can help. Marketing should coordinate that explanation with the teams responsible for payer information and financial communications.
Consider a hypothetical system launching a regional campaign after acquiring several practices. One clinic accepts online requests, another schedules by telephone, and a third directs certain appointments through a central team. Sending all campaign traffic to a uniform booking instruction creates confusion. A coordinated launch should confirm these local pathways before presenting the combined organization as a single access experience.
Language support, accessibility, parking, transport, and arrival instructions can also affect whether someone follows through. The appropriate information depends on the service and community. Teams should test the journey with people who do not already know the institution, including those using assistive technology or seeking help for another person. Their questions often reveal gaps that internal navigation reviews miss.
Make accuracy a maintained capability
We would give consequential directory fields a named owner, a review process, and a route for reporting errors. Changes with an immediate effect on access deserve a defined publishing response. Campaign teams need to know when a promoted location cannot fulfill its stated offer, so they can coordinate an appropriate change with operations.
Mergers and rebrands deserve particular attention to continuity. Existing names, referral habits, saved links, and printed materials may remain in circulation. The transition plan should help audiences recognize the new relationship and find the correct destination. Retiring an old page without a useful onward route can discard trust the organization has already earned.
The executive measure is whether accurate information helps people reach an appropriate next step. Track consequential errors, unresolved updates, misrouted inquiries, and the effort required to correct them. A maintained location system makes future campaigns easier to launch and gives clinical teams a public presence they can rely on.
5. Clinical credibility needs a publishing discipline
Useful healthcare content connects a clear public question with appropriate expertise, inspectable evidence, and a responsible next step.
Healthcare organizations possess knowledge that audiences need, but that knowledge rarely arrives in a form ready for public use. A clinician’s explanation, a research paper, a service description, and a patient’s experience serve different purposes. The editorial task is to turn appropriate source material into content that people can understand without losing the distinctions that make it trustworthy.
We would begin with the question the audience is trying to answer. Someone comparing service options may need to understand the team, location, access process, and what an initial conversation involves. A referring clinician may need a more technical account of capability. A community partner may need an explanation of eligibility and support. One broad promotional page will rarely satisfy all three.
KFF’s March 2026 poll found that 80% of adults had used a healthcare professional for health information in the past year, alongside 68% using internet search and 32% using AI tools. Audiences can use several sources. For institutional content, that suggests connecting discoverable explanations with clearly identified professional expertise. [4]
| Information source | Adults reporting past-year use |
|---|---|
| Healthcare professional | 80% |
| Internet search | 68% |
| AI tools | 32% |
KFF, published March 25, 2026. Survey of 1,343 U.S. adults, February 24–March 2. Past-year use for physical or mental health information or advice. Responses overlap and should not be summed; these are not channel market shares. [4]
Define the claim before selecting the format
A content brief should identify the proposed claim, supporting source, clinical reviewer, intended audience, and next action. Research findings need enough context to show which population and conditions they describe. Statements about a particular service need confirmation from its responsible clinical and operational leaders. A compelling headline should remain consistent with the evidence supporting the body of the page.
Consider a hypothetical specialty program preparing a video about a new service. The marketing team wants to explain the patient experience; clinicians want to clarify who may be appropriate for assessment; operations needs to describe the intake process. Agreeing on those purposes before production gives the film a useful structure and reduces avoidable revisions after an interview has been recorded.
Patient stories require their own editorial judgment. An individual experience can make care understandable while remaining one person’s account. Teams should avoid implying that another patient can expect the same result. Participation should be an informed choice, with the organization’s responsible owners confirming the intended use, permissions, and practical limits on withdrawing material after distribution.
Clinical review works best when it is planned as part of production. Assign a reviewer with relevant expertise, explain the question being asked, and reserve time for substantive corrections. Reviewers should see the final context, including headlines, captions, graphics, and calls to action. An accurate interview can acquire a different meaning when edited into a short advertisement.
Make the content useful after publication
Plain language and readable structure help audiences act on the explanation. Define unfamiliar terms where they matter, make navigation predictable, and connect the content to a clear next step. The organization can evaluate understanding through audience review and practical task testing. A readability score alone cannot establish whether a person understands the service or knows how to proceed.
Published assets should retain their source, review date, responsible owner, and approved uses. A change in staff, availability, evidence, or service design may require updates across several formats. Building a reusable library with that context protects the value of original production and makes future work more efficient for clinical contributors.
Leadership should commission a sustainable publishing commitment. The budget needs to cover evidence gathering, clinical input, writing, design, production, accessibility, and maintenance. When those responsibilities are explicit, content can support patient understanding, clinician confidence, recruitment, and institutional reputation through material the organization is prepared to stand behind.
6. Measurement needs a deliberate data boundary
Leadership should understand what information is collected, where it goes, and what decision it supports.
Healthcare marketing measurement starts with a business question and an approved means of answering it. A team may need to understand which public service explanations receive attention, whether scheduling routes work, or how a defined campaign relates to completed appointments. Those questions do not require every system to receive the same information. The architecture should reflect the purpose and the sensitivity of the data involved.
Public websites, appointment forms, authenticated portals, call systems, and advertising platforms create different contexts. A familiar analytics tag can collect more than its owner expects through page addresses, event labels, form fields, or connected services. The institution should inspect the actual configuration and disclosures, including what changes when a person moves between public information and a more sensitive interaction.
HHS’s tracking guidance acknowledges a court decision vacating part of its treatment of an IP address linked to a visit to an unauthenticated health-related webpage. The guidance also addresses other disclosures of protected health information and explains that cookie banners are not HIPAA authorizations. The status of a particular implementation requires review of its facts. [5]
Our operating recommendation is a documented data map owned jointly by marketing, technology, privacy, and security. Identify each collection point, the information transmitted, the receiving party, the intended use, access permissions, and retention. Establish who can approve changes. Vendor branding, server-side routing, or hashing an identifier should not be treated as a substitute for determining whether the actual use is appropriate.
| Decision | Information to define | Responsible coordination |
|---|---|---|
| Improve a public explanation | Approved measures of content use and task difficulty | Marketing, digital experience, privacy |
| Repair a scheduling route | Technical errors and appropriately handled operational feedback | Access operations, technology, security |
| Assess appointment progression | Defined internal records and a suitably limited reporting output | Authorized operations, analytics, privacy |
| Evaluate media delivery | Permitted platform reporting and verified campaign definitions | Media operator, marketing, privacy |
| Interpret financial contribution | Reconciled costs and finance-approved outcome definitions | Finance and authorized analytical teams |
Gigawatt Group proposed planning model. Actual collection, access, disclosure, contracts, and retention require review by the institution’s responsible owners. The table does not establish that any particular implementation is permissible.
Healthcare organizations also need to consider obligations beyond HIPAA. FTC guidance describes how the FTC Act and, for covered types of businesses, the Health Breach Notification Rule can apply to consumer health information. A statement that a product is outside HIPAA does not settle all privacy responsibilities. The institution’s legal and privacy teams should determine the applicable requirements. [6]
The useful analytical boundary often separates controlled internal reconciliation from external campaign reporting. Authorized teams may be able to reconcile a defined operational record internally and provide an appropriately limited result to decision-makers. That arrangement still needs a specific design, suitable permissions, and a review of whether small groups or combined fields expose information the report should not disclose.
Some measurement will remain incomplete. A person may see an advertisement, discuss the service with a clinician, and book through an unlinked telephone route. Another may interact across devices. Leadership should receive an honest account of those limits. The desire for a complete attribution diagram does not justify collecting or disclosing information without a defensible purpose and authority.
The commercial brief should price this work. Tag review, event definitions, vendor coordination, technical validation, and reconciliation consume expertise and time. Assign responsibility for maintaining the approved configuration after launch, because websites and integrations change. A useful agency relationship leaves the institution with understandable measurement and a clear process for evaluating the next change.
7. Paid media should be evaluated against usable response
Low inquiry costs can coexist with weak appointment completion, while capacity and audience differences complicate comparison.
A healthcare media plan should explain why each channel fits the audience’s task. Search can reach people expressing an immediate information need. Video can explain an unfamiliar service or affiliation. Local media can support awareness of a new location. Professional channels can reach clinicians or institutional buyers. The appropriate mix follows the assignment, the available access, and the evidence the organization needs.
Audience strategy also needs to reflect the service and the platform. Google restricts advertiser-curated targeting for promotions in sensitive health categories. That policy is not a general prohibition on healthcare advertising, and platform eligibility does not establish legal permission. Teams should verify the permitted methods for the actual creative, audience, and destination before promising a particular targeting approach. [7]
Consider three hypothetical campaigns with $36,000 in total program costs each. Campaign A produces 600 inquiries and 120 completed appointments; B produces 400 inquiries and 200 completed appointments; C produces 300 inquiries and 150 completed appointments. Their cost per inquiry is $60, $90, and $120. Cost per completed appointment is $300, $180, and $240, respectively.
| Program | Inquiries | Completed appointments | Cost per inquiry | Cost per completed appointment |
|---|---|---|---|---|
| A | 600 | 120 | $60 | $300 |
| B | 400 | 200 | $90 | $180 |
| C | 300 | 150 | $120 | $240 |
Constructed example, not client results, a forecast, or a causal comparison. Each program costs $36,000 and uses the same observation window. Clinical appropriateness, incremental appointments, revenue, and financial return are not established.
The example shows why leadership should examine the progression after an inquiry. A has the lowest inquiry price, while B has the lowest observed cost per completed appointment. This comparison does not establish that B’s media caused more appointments or that its approach should receive unlimited additional spending. The audiences, services, access conditions, and sources of existing demand could differ.
A useful review examines those differences before making a recommendation. Was one location able to offer appointments sooner? Did one campaign attract more relevant requests? Were records counted consistently? Did follow-up occur? Was a service receiving substantial referrals from elsewhere? The agency and operational owners should work through the explanations instead of treating the advertising platform as the sole source of performance.
Completed appointments also require context. Marketing does not determine clinical appropriateness, care quality, or the value of an individual patient. Finance may need a separate contribution analysis with defined costs and timing. Clinical and operational teams retain responsibility for their own outcomes. The campaign report should stay precise about the result it has actually counted.
Active management means making timely decisions within approved boundaries. An operator might reduce repeated exposure, correct a destination, shift delivery toward an available location, or pause a message that no longer reflects service conditions. A change to a clinical claim, audience method, or data flow requires the relevant institutional approval. Those decision routes should be established before launch.
We would commission a bounded initial program with a clear review point and explicit conditions for expansion. The proposal should account for media, creative, measurement, campaign operation, and internal dependencies. Leadership then buys the ability to learn and act while the campaign is live, with the next commitment tied to the remaining opportunity and the institution’s ability to respond.
8. Referral and clinician relationships need their own strategy
Professional trust depends on useful information and a referral process that clinical teams can sustain.
A referring clinician brings a different task to a healthcare website than a prospective patient. The clinician needs to establish whether a service is appropriate, which specialist or location can receive the referral, what information the receiving team needs, and how communication will continue. A polished service page can support that decision when it connects to accurate professional information and a workable process.
Consider a hypothetical regional specialty group introducing a new access program. The campaign explains the clinical scope and gives referring practices a clear contact route. Its usefulness depends on whether the directory is current, the receiving team understands the offer, and the instructions reflect actual scheduling requirements. Marketing should confirm those conditions with the clinical and access owners before promoting the program.
Make professional information useful at the point of decision
We would organize referral resources around the questions practices repeatedly ask. Explain the service scope, responsible team, locations, referral route, required records, and expected next step. Use clear ownership for updates when staff, schedules, or processes change. Clinicians should review substantive descriptions, while access teams confirm that the operational instructions match the work they perform.
The supporting content can include specialist introductions, concise research explanations, service updates, and practical educational events. Each needs a defined audience and purpose. A professional briefing may help establish expertise; a referral instruction page helps someone act. Reporting should preserve those distinctions instead of presenting every download or event attendee as evidence of a new clinical relationship.
Communication after the referral deserves equal attention. The responsible teams should agree how a referring practice learns that information was received, whether further material is needed, and how relevant follow-up reaches the appropriate clinician. Marketing can help design clear materials and consistent communication patterns. Clinical and operational leaders need to own the decisions and exchanges that involve patient care.
A useful performance account therefore connects relevant professional reach with observable relationship activity. Depending on available records, that might include qualified inquiries, completed referral submissions, timely acknowledgment, or progression through an agreed access process. Interpretation should account for existing relationships and changes in available appointments. Campaign attribution alone cannot explain why a clinician chose a particular destination.
Keep workforce recruitment tied to the employment experience
Clinician recruitment involves another decision journey. Candidates assess clinical expectations, scheduling, leadership, professional support, location, and the credibility of the people describing the organization. Employer content should help suitable candidates evaluate those conditions. A recruitment campaign becomes more useful when its public account matches the information recruiters and hiring leaders provide later.
The team should distinguish candidate interest from eligibility, interviews, offers, and completed hiring. An application volume target can create work without improving the candidate pool. Recruiting leaders should define a qualified response and explain where the process loses suitable people. Marketing can then address an unclear proposition, an unsuitable audience, or a difficult application experience.
For executive planning, referral development and workforce recruitment deserve separate briefs, owners, and evidence. Both depend on professional credibility and reliable follow-through. Buying the relevant communication capability means funding the information and operating coordination that make those relationships easier to establish and maintain.
9. Healthcare SEO and AI visibility depend on a reliable public record
Discovery should lead to accurate explanations, clear institutional identity, and a usable route to the appropriate team.
Healthcare SEO helps people discover services, clinicians, locations, and expertise through search. Generative engine optimization concerns how that information is found and represented in AI-assisted answers. For healthcare organizations, the practical priority is a public record that remains accurate enough to support consequential questions. Visibility has limited value when the answer points to an unavailable service or misstates what the institution provides.
KFF’s June 2026 poll found that 29% of adults reported using AI tools or chatbots for health information or advice at least monthly. The survey measures reported behavior, not the accuracy of the answers received or their effect on clinical decisions. It supports taking AI-mediated discovery seriously while maintaining a clear distinction between public education and individual care. [9]
Start with the institution’s most consequential pages. Provider profiles need accurate affiliations, locations, specialties, and contact routes. Service pages need reviewed descriptions and clear availability information. Research explanations need sources, dates, methods, and limitations. If several acquired practices retain older domains or inconsistent names, search users may encounter a fragmented account of the same organization.
Google’s guidance for AI features continues to emphasize established SEO foundations, useful content, accessible text, and structured data that matches the visible page. It specifies no special AI schema or new machine-readable text file requirement. Meeting the technical conditions does not guarantee inclusion in generated answers. [8]
Our recommendation is to organize publishing around real questions the institution is qualified to answer. A service explanation can clarify what a program does, which team provides it, and how a person can ask about access. A research page can explain an institution’s contribution without converting preliminary evidence into a treatment promise. A location page can resolve practical uncertainty that a broad educational article leaves untouched.
Discovery architecture should connect those assets. A service page can link to the relevant specialists, locations, practical access information, and reviewed explanations. Give each important topic a clear primary destination; maintain useful redirects when practices merge or services move. Search specialists should investigate indexing, competing pages, navigation, and outdated listings before prescribing a large volume of new articles. The priority is whether a person can find a coherent account of the service and continue toward an appropriate next step.
AI-assisted production needs the same discipline. A generated draft can make a source sound more certain, omit a limitation, or confuse one location with another. Review the underlying evidence and final meaning before publication. Patient records and other sensitive material need approved handling, independent of whether a tool makes summarization convenient. Production speed should be evaluated alongside the work required to verify and maintain the output.
Measurement should separate observable search visibility, referral visits, meaningful website actions, and controlled operational results. Citation monitoring can help inspect representation within a defined sample of queries and systems. It cannot provide a complete census of every answer a prospective patient sees. A citation should not receive automatic revenue credit or be presented as a clinical endorsement.
The 2027 investment case is therefore selective. Maintain useful expertise, repair inaccurate identity and location information, improve important service journeys, and retire material that no longer serves a defensible purpose. A strong search engagement leaves the institution with a more reliable public knowledge base and a clear account of how discovery is being evaluated.
10. Pharma and medtech require a different commercial pathway
Product education, professional evaluation, procurement, and implementation create distinct responsibilities for healthcare marketers.
A health system promoting an available service and a company introducing a healthcare product face different commercial decisions. The service journey may end in a scheduled encounter. A product journey can involve patient education, clinical assessment, evidence review, purchasing committees, operational planning, and adoption support. The brief should identify which decision the proposed communication is intended to help.
For a pharmaceutical organization, audience definitions shape the work from the beginning. A patient resource, professional educational asset, corporate explanation, and product promotion can have different purposes and review needs. The organization should establish the intended audience, approved claims, supporting materials, and responsible reviewers before creative development. That clarity helps teams produce material that can move through the client's medical, regulatory, and legal review process.
FDA’s prescription-drug promotion guidance emphasizes truthful, balanced communication of benefits and risks. Product classification, claims, audience, and format need review by the organization’s responsible medical, legal, and regulatory owners. The review requirements for a product promotion should be established separately from those for a provider-service campaign. [10]
Preserve the relationship between a claim and its evidence
Creative teams need enough context to explain what the evidence supports. Relevant context can include the studied population, intervention, comparison, endpoints, and limitations. Product status and intended use also need accurate descriptions. A strong headline should remain consistent with the underlying evidence when it becomes a short video, paid placement, presentation, or landing page.
We recommend maintaining a shared record of approved claims, sources, versions, and permitted contexts. This helps a team recognize when a useful explanation can be reused and when a different audience or format requires another review. The scope should include the time needed to resolve questions. A production schedule built around instant approval transfers uncertainty into the campaign's delivery period.
Patient-facing content should make the intended next action understandable. That action might involve learning about a condition, preparing questions for a clinician, or finding an appropriate support resource. The communication should identify its purpose clearly and route personal medical questions to a suitable clinical channel. A marketer's conversion definition needs to respect the role of the professionals making care decisions.
Consider a hypothetical pharmaceutical launch with separate workstreams for professional awareness, approved product information, and patient support resources. The professional pathway could connect relevant audience reach with a reviewed evidence summary, an appropriate information request, and documented follow-up by the responsible team. The patient pathway could explain where to find approved support information and how to raise questions with a clinician. Each pathway needs its own destination and response owner.
The commercial review should distinguish exposure, engagement with approved material, relevant requests, and the next observable relationship step. Account planning may also need to consider access and reimbursement processes, with specialist teams owning those details. Prescription decisions remain clinical decisions. Marketing reports should state the limits of what their evidence establishes and use only information the organization has approved for that purpose.
For medtech, connect demand with evaluation and implementation
Consider a hypothetical device company seeking hospital adoption. Interest from an individual clinician may initiate the conversation, while other participants examine evidence, workflow, training, support, procurement, and system requirements. An effective content program gives each participant relevant information and helps the commercial team understand what the institution needs before it can make a decision.
The agency brief should therefore extend through the qualified opportunity. Define what makes an institution relevant, who needs to participate, which evaluation steps are observable, and what the sales team will record. A demonstration request can indicate interest. A documented evaluation with the appropriate stakeholders establishes a different level of progression. Report both accurately, with the time window and relationship history visible.
Implementation materials can also belong in the marketing investment. Clear onboarding explanations, training resources, and consistent support information help the organization deliver what its commercial narrative promised. The product and clinical teams should own technical accuracy. Marketing can make approved information easier to use across the people responsible for adoption.
For 2027, the strongest life-sciences brief will connect audience strategy, evidence, review, commercial progression, and the practical conditions for adoption. Leadership should compare agencies on their ability to manage those relationships and produce useful work within them. Provider appointment campaigns and product commercialization can share creative disciplines while retaining distinct measures of progress.
11. Executive reporting should explain the next investment
The board and leadership team need a clear relationship among spending, access, observed response, and the recommendation.
Healthcare marketing analytics should help leadership make a decision. A useful report starts with the question under consideration: expand a campaign, improve a destination, redirect demand, support a referral initiative, or investigate a performance change. It then presents the evidence relevant to that choice. A collection of favorable channel percentages gives executives little help if the operating implications remain unexplained.
Begin with the complete investment account. Identify media, production, agency operation, technology, measurement, and material internal dependencies. Explain what has been committed and what can still change. When a project benefits multiple service lines or locations, agree how shared costs will be treated. Finance should own the interpretation of financial contribution, including the timing and limitations of the available records.
The response account should distinguish inquiries, successful contact, scheduling, and completed appointments where they can be responsibly observed. Professional engagement and commercial opportunities need their own definitions. An executive should be able to tell whether a reported conversion is a website event, a verified operational record, or attribution credit assigned by a platform.
| Evidence layer | What leadership can inspect | Decision supported |
|---|---|---|
| Investment | Committed spending, complete costs, remaining flexibility | Continue, revise, or reallocate the commitment |
| Delivery | Audience reach, published work, functioning destinations | Correct execution or change the distribution plan |
| Access and response | Contact, scheduling, completion, capacity context | Improve the journey or adjust demand generation |
| Professional or commercial progression | Relevant referrals, candidates, or product evaluations | Support the appropriate relationship pathway |
| Institutional learning | Test findings, decisions, maintained assets | Define the next investment and accountable owner |
Gigawatt Group proposed executive reporting structure. Record the period, source, limitations, and owner for each measure. Operational observation and platform attribution answer different questions.
A campaign can influence several steps without proving that it caused the final outcome. For some assignments, a thoughtfully designed experiment may help assess incremental contribution. Its feasibility depends on scale, spillover, implementation, and the institution’s service responsibilities. Comparisons should not compromise access or clinical priorities. When a strong causal design is unavailable, the report should say what the observational evidence supports.
Different reporting clocks deserve recognition. Media operators need timely information about delivery and broken journeys. Access teams need actionable volume and response information. Finance may require later reconciliation. Clinical quality and patient experience measures follow their own definitions and periods. Combining these into a single monthly number can create certainty that the underlying systems do not provide.
Location comparisons also need context. Different services, opening hours, referral patterns, capacity, and populations can produce different results. A league table of cost per appointment may reward a location with easier operating conditions. Leadership should see enough context to distinguish a campaign problem from a service constraint and to identify where a successful approach can reasonably be adapted.
The report should retain a decision record: what the team observed, what it changed or held, who approved the decision, and what happened afterward. This record makes active management inspectable and preserves institutional knowledge. It also helps a new operator understand why an apparently obvious change was previously rejected or deferred.
For renewal decisions, include the capability the work leaves behind. Accurate provider information, reusable creative with clear rights, reviewed content, understood measurement, and documented workflows can reduce future effort. The strongest executive account connects those assets with current performance and a specific next commitment. Leadership can then authorize action with a clear owner, expected output, and understood uncertainty.
12. The 2027 agency brief should buy coordinated execution
A credible partner proposal makes strategy, creative, access, media, and measurement work together within the institution’s responsibilities.
A healthcare organization preparing an RFP should identify the decision the engagement needs to support. The priority might be launching a location, strengthening a service line, explaining an affiliation, improving patient access, supporting clinician relationships, or developing a product-specific commercial program. A precise assignment allows competing agencies to address the same problem and makes differences in approach easier to evaluate.
The brief should describe the intended audiences, existing brand and content assets, current systems and suppliers, available budget, launch requirements, and internal approval owners. Include known constraints that could affect delivery. An access bottleneck, incomplete provider data, or limited clinical-review capacity changes the work an agency needs to price and sequence. Making these conditions visible improves the usefulness of the response.
Ask each partner to identify the work it will own and the dependencies it expects the institution to resolve. Strategy should connect to an executable content and media plan. Creative should have an evidence and approval route. The destination should support the intended action. Measurement should have agreed definitions and approved data handling. These relationships should appear in the scope and schedule.
Existing expertise deserves a fair account. A health system may already have a capable access team, an effective platform partner, a specialist clinical writer, or a trusted regional production firm. A new agency should explain how it will coordinate with those resources. Consolidation can simplify some relationships while introducing transition costs and responsibilities that leadership needs to understand.
An illustrative first ninety days can make the proposed engagement concrete. The first stage confirms objectives, audience needs, access conditions, evidence, and ownership. The second develops and validates a bounded set of improvements. The third supports controlled delivery and an early review. A live launch or a complex technology dependency may require a different sequence; the plan should reflect the institution’s actual calendar.
Commercial evaluation should include the people doing the work, their availability during consequential periods, specialist fees, and the authority to make approved campaign changes. Confirm appropriate account access, creative rights, exportable records, and transition responsibilities. The organization should understand what it will retain when the engagement ends and which platform or licensing restrictions limit transfer.
Our outlook for 2027 is that healthcare organizations will increasingly judge marketing partners by their ability to connect credible communication with operational reality. AI will change discovery. Automation will change production and buying. The enduring requirement will be an accurate promise, an accessible next step, and evidence that helps leadership decide what to do next.
Invite Gigawatt Group to propose a defined scope across healthcare brand strategy, content and creative, websites, paid media, search visibility, and reporting. Begin with the institutional objective, intended audiences, current systems, available investment, and decision deadline. The strongest engagement leaves the organization better equipped to explain its value, support appropriate access, and make the next investment with clearer evidence.
Relevant healthcare execution
Gigawatt Group’s healthcare portfolio describes its work for Metro Immediate & Primary Care, including a coordinated campaign across television, radio, paid digital, social, outdoor, and refreshed collateral. The portfolio provides a relevant example of integrated healthcare communication. A new engagement needs its own audience, clinical and operational review, scope, and performance definitions. [11]
Bring the next healthcare investment into a clearer brief
Invite Gigawatt Group into your healthcare RFP or RFI for strategy, content and creative, websites, paid media, search visibility, and measurement. Share the service or product priority, audiences, current partners, access conditions, and decision your leadership team needs to make.
Executive questions
What is healthcare digital marketing strategy?
Healthcare digital marketing strategy connects institutional priorities with audiences, credible content, usable digital experiences, media, and evidence. For providers, it also coordinates promotion with scheduling capacity, clinical review, accurate location information, and responsible handling of data.
How should health systems measure patient acquisition?
Distinguish inquiries, successful contact, scheduled appointments, and completed visits. Define the observation period and responsible source for each. Assess access constraints and complete program costs, while keeping clinical appropriateness, care quality, financial interpretation, and marketing attribution separate.
Why should service-line marketing include access operations?
Campaigns generate expectations that scheduling and service teams must fulfill. Access operations can confirm availability, routing, referral requirements, and material changes. This coordination helps leaders decide whether to expand promotion, change the message, improve the journey, or pause delivery.
How should healthcare organizations approach SEO and AI visibility?
Maintain accurate provider, service, and location information, supported by useful reviewed content and clear institutional ownership. Evaluate search visibility and AI representation separately from website response and operational outcomes. Technical eligibility does not guarantee ranking, citations, or appointment growth.
How do pharma and medtech marketing differ from provider marketing?
Pharma and medtech programs can involve product-specific claims review, professional education, procurement, evaluation, and implementation. Their briefs need distinct audience definitions, evidence requirements, reviewers, and commercial milestones. A product evaluation and a provider appointment represent different forms of progress.
What belongs in a healthcare marketing RFP?
Include the institutional objective, audience, service or product scope, available budget, existing systems and partners, approval owners, access constraints, deadlines, and required evidence. Ask agencies to define responsibilities, dependencies, specialist needs, complete costs, data handling, and what the organization will retain.
Related capabilities
Research, methods, and sources
Research reviewed November 5, 2026. Published findings are distinguished from Gigawatt Group recommendations. Organizational examples and campaign programs are illustrative unless expressly identified as portfolio work. The 2027 outlook expresses management judgments. Regulatory and platform references address their stated scope; implementation decisions require the institution’s responsible review.
- AMN Healthcare, 2025. Survey of Physician Appointment Wait Times and Medicare and Medicaid Acceptance Rates. Specified non-emergent new-patient scenarios across 15 metropolitan areas.
- ASTP/ONC, July 2025. Individuals’ Access and Use of Patient Portals and Smartphone Health Apps, 2024. Data Brief 77, HINTS. Weighted adult self-reports.
- Agency for Healthcare Research and Quality. Health Literacy Universal Precautions Toolkit. Guidance on reducing complexity and supporting understanding. Its application to marketing task design is a recommendation in this report.
- KFF, March 25, 2026. Use of AI for Health Information and Advice. February 24–March 2 poll of 1,343 U.S. adults. The chart uses past-year reported information sources, with overlapping responses.
- U.S. Department of Health and Human Services. Use of Online Tracking Technologies by HIPAA Covered Entities and Business Associates. Guidance acknowledges a partial court vacatur. Application depends on the information, context, parties, and actual disclosure.
- Federal Trade Commission. Collecting, Using, or Sharing Consumer Health Information. Explains responsibilities under HIPAA, the FTC Act, and the Health Breach Notification Rule according to the entity and facts.
- Google Ads. Personalized advertising: health. Official policy concerning sensitive health categories and audience targeting. Platform policy and legal permission require separate consideration.
- Google Search Central. AI Features and Your Website. Official guidance on technical eligibility, useful content, and structured data. It does not guarantee inclusion or visibility.
- KFF, June 17, 2026. Use of Social Media and AI for Health Information and Advice. May 7–31 survey of 2,480 U.S. adults. Monthly AI use is a different measure from the March poll’s past-year use.
- U.S. Food and Drug Administration. Bad Ad Program. Prescription-drug promotion guidance concerning accurate, balanced, and nonmisleading communication.
- Gigawatt Group. Healthcare Marketing Agency. Healthcare services and portfolio. The Metro Immediate & Primary Care example was reviewed in the preceding healthcare portfolio; no causal or numerical performance claim is inferred here.
Healthcare Strategy, Creative, Digital Experience, and Measurement
Gigawatt Group’s healthcare marketing services connect institutional strategy with content, experiences, media, and evidence. An engagement can address a defined provider growth priority or a distinct pharmaceutical or medical technology communication assignment.
Strategy and Alignment
- Institutional positioning and audience priorities
- Service-line and location campaign planning
- Patient, professional, and buyer journeys
- Defined responsibilities and decision criteria
Content and Creative
- Brand narratives and campaign development
- Original video, design, and storytelling
- Content coordinated with clinical reviewers
- Adaptable materials for service and product teams
Digital Experience and Media
- Websites and campaign destinations
- Search and AI visibility strategy
- Paid media and active campaign management
- Coordination with access and platform partners
Measurement and Learning
- Agreed response and conversion definitions
- Measurement coordinated with institutional data owners
- Campaign and operational evidence review
- Executive reporting and investment recommendations
Each proposal should define GG’s responsibilities, specialist relationships, required access, review owners, fees, and reporting. Clinical decisions, legal determinations, data permissions, and operational commitments remain with the responsible institutional teams.